Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Intravenous Administration Errors Intercepted by Smart Infusion Technology in an Adult Intensive Care Unit.

Ibarra-Pérez R, Puértolas-Balint F, Lozano-Cruz E, Zamora-Gómez SE, Castro-Pastrana LI.

J Patient Saf. 2017 Apr 1. doi: 10.1097/PTS.0000000000000374. [Epub ahead of print]

PMID:
28368966
2.

Pharmacogenomic investigation of adverse drug reactions(ADRs): the ADR prioritization tool, APT.

Shaw K, Amstutz U, Castro-Pastrana L, Loo TT, Ross CJ, Ito S, Reider MJ, Maher M, Macleod S, Koren G, Hayden MR, Carleton BC.

J Popul Ther Clin Pharmacol. 2013;20(2):e110-27. Epub 2013 May 3.

PMID:
23824325
3.

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

Amstutz U, Ross CJ, Castro-Pastrana LI, Rieder MJ, Shear NH, Hayden MR, Carleton BC; CPNDS Consortium.

Clin Pharmacol Ther. 2013 Jul;94(1):142-9. doi: 10.1038/clpt.2013.55. Epub 2013 Mar 18.

4.

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.

Aminkeng F, Ross CJ, Rassekh SR, Brunham LR, Sistonen J, Dube MP, Ibrahim M, Nyambo TB, Omar SA, Froment A, Bodo JM, Tishkoff S, Carleton BC, Hayden MR; Canadian Pharmacogenomics Network for Drug Safety Consortium.

Pharmacogenomics J. 2014 Apr;14(2):160-70. doi: 10.1038/tpj.2013.13. Epub 2013 Apr 16.

5.

Nutritional support and cardioprotection with L-carnitine: prescription appropriateness and safety concerns in Mexican neonates.

Gómez-Oliván LM, Valdés-Alanis A, Castro-Pastrana LI, Galar-Martinez M, Romero-Castillo CA.

J Popul Ther Clin Pharmacol. 2011;18:e166-73. Epub 2011 Mar 21.

PMID:
21471608
6.

Pharmacogenomics of serious adverse drug reactions in pediatric oncology.

Ross CJ, Visscher H, Rassekh SR, Castro-Pastrana LI, Shereck E, Carleton B, Hayden MR.

J Popul Ther Clin Pharmacol. 2011;18:e134-51. Epub 2011 Mar 21. Review.

PMID:
21467604
7.

A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children.

Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, Castro-Pastrana LI, Rieder MJ.

J Popul Ther Clin Pharmacol. 2011;18:e121-33. Epub 2011 Mar 21. Review.

PMID:
21467603
8.

Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS).

Castro-Pastrana LI, Ghannadan R, Rieder MJ, Dahlke E, Hayden M, Carleton B.

J Popul Ther Clin Pharmacol. 2011;18:e106-20. Epub 2011 Mar 21.

PMID:
21467602
9.

Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge.

Castro-Pastrana LI, Carleton BC.

J Popul Ther Clin Pharmacol. 2011;18:e76-88. Epub 2011 Mar 21.

PMID:
21467599

Supplemental Content

Loading ...
Support Center